Wellness Unmasked Weekly Rundown: Inside the CDC’s Review of Newborn Hepatitis B Vaccination

Summary

Podcast Summary: Wellness Unmasked Weekly Rundown — Inside the CDC’s Review of Newborn Hepatitis B Vaccination

Podcast: The Clay Travis and Buck Sexton Show (Wellness Unmasked segment)
Host: Dr. Nicole Saffire
Date: December 5, 2025
Episode Theme: Inside the CDC’s Review of Newborn Hepatitis B Vaccination

---

Episode Overview

This episode, hosted by Dr. Nicole Saffire, provides an in-depth look into the CDC’s Advisory Committee on Immunization Practices (ACIP) discussions concerning the longstanding recommendation for universal hepatitis B vaccination at birth in the U.S. Dr. Saffire recaps the recent ACIP meetings, shares the divided opinions among experts, examines evidence for and against immediate newborn vaccination, and offers her own professional insights into the future of hepatitis B vaccination policy.

---

Key Discussion Points & Insights

1. ACIP Meetings and the Current Debate

• Background:

  • ACIP is reconsidering whether all newborns should receive the hepatitis B vaccine at birth, especially when mothers have already tested negative for the virus.
  • Infants born to hepatitis B positive mothers—or whose maternal status is unknown—would still absolutely receive the birth dose.
  • The current debate targets ONLY infants whose mothers are confirmed hepatitis B negative.

• Quote:

  "Do we need to universally vaccinate at birth, especially in mothers who are testing negative? That's a really good question."
  — Dr. Nicole Saffire (02:35)

2. Arguments For and Against the Universal Newborn Vaccine Dose

• Pro-Vaccine Arguments:

  • Decades of data indicate a clear benefit: sharp declines in hepatitis B infections since the universal newborn vaccination policy was implemented.
  • Vaccine is considered safe in newborns, based on historical safety data.
  • Concern that changing the recommendation may reduce access or uptake.

• Skeptical Viewpoints:

  • Critics argue the decline in cases cannot be attributed solely to newborn vaccination; improvements in blood and organ screening, dialysis practices, and needle exchange programs also played major roles.
  • No direct data presented to support delaying the dose from birth to two months.
  • Concerns about the risk of fever in newborns following vaccination, which can result in invasive medical interventions due to the seriousness of fevers in this age group.

• Quote:

  "It’s dishonest to say that [the vaccine] is wholly responsible for the decline in hepatitis B cases... There are many variables that have contributed."
  — Dr. Nicole Saffire (03:50)

  "One of the well-documented risk factors for vaccines is that babies, specifically, get fevers after vaccines... Because fevers in a newborn is really a medical emergency."
  — Dr. Nicole Saffire (05:15)

3. Timing and Data Gaps

• Dr. Saffire notes that the discussions are focused on the timing of the first dose, not its eventual necessity.

• She expresses skepticism over the lack of data for giving the first dose at two months rather than at birth, questioning why not even later—such as six months or adolescence—when hepatitis B risk increases due to lifestyle factors.

• Compares proposed strategies for hepatitis B with established adolescent vaccination timing for HPV.

• Quote:

  "Why two months? Why not six months? Why not six years?... Why not consider the hepatitis B vaccine around the same time [as the HPV vaccine]?"
  — Dr. Nicole Saffire (07:03)

4. Concerns Around Policy Decisions Without Strong Evidence

• Frustration that the change under consideration is not supported by clear scientific evidence, but rather seems driven by policy discussions and a desire to promote patient autonomy.

• Warns that undermining trust with changes not clearly based on data may hurt public confidence in vaccines.

• Quote:

  "Changing a longstanding newborn recommendation without presenting new evidence… That’s not science, it’s policy making without data."
  — Dr. Nicole Saffire (08:10)

5. Implications for Parental and Clinical Autonomy

• Anticipates ACIP will recommend more individualized decisions, with clinicians and parents making choices based on maternal risk factors.

• Stresses that most likely, the recommendation will be for mothers with negative hepatitis B status, and not living high-risk lifestyles, to potentially delay the vaccine. However, the option to vaccinate will remain after clinician-parent discussion.

• Quote:

  "The mantra of this current administration... is putting the autonomy back with the patients, back with the clinicians."
  — Dr. Nicole Saffire (08:45)

6. Importance of Maternal Screening

• Highlights the necessity to ensure all pregnant women are properly screened for hepatitis B (and other infectious diseases), to maximize infant protection.

• Quote:

  "We need to make sure that all pregnant women are getting the screening they need, not just for hepatitis B, but for HIV and other communicable diseases."
  — Dr. Nicole Saffire (09:45)

---

Notable Quotes & Moments

• On the ACIP Meeting Tone:

  "A lot of the members... love to hear themselves talk... the meeting has been messy."
  — Dr. Nicole Saffire (02:28)

• On Evidence and Vaccine Trust:

  "If we want families to trust vaccine recommendations, then every change must be backed by transparent, compelling evidence."
  — Dr. Nicole Saffire (09:55)

---

Timestamps for Important Segments

• 02:23 — Dr. Nicole Saffire opens episode and describes the CDC ACIP meeting
• 03:00 — Debate overview: Universal newborn vaccine vs. selective/delayed approach
• 04:00 — Pro-vaccine arguments and critique of data interpretation
• 05:15 — Safety concerns: fevers in newborns and hospital interventions
• 06:30 — Questioning the timing of vaccination and comparison to HPV vaccine policies
• 08:10 — Criticism of policymaking without strong evidence
• 08:45 — Predicted outcome: clinician and parental autonomy in vaccine timing
• 09:45 — Call for universal maternal screening

---

Conclusion and Tone

Dr. Saffire closes by emphasizing the powerful track record of the hepatitis B birth dose in modern pediatrics, but pushes for transparent, evidence-driven changes to vaccine recommendations. While expressing discomfort with the conjecture seen in the ACIP meetings, she welcomes the open discussion as a step toward building public trust.

Ending Quote:

"I am still very glad to see the conversation being had."
— Dr. Nicole Saffire (10:10)

---

Useful Episode for:

• Parents curious about the science and policies behind newborn vaccinations
• Healthcare professionals navigating evolving vaccine recommendations
• Listeners interested in the intersection of public health policy and medical evidence

Transcript

[Kal Penn]

Hey audiobook lovers. I'm Kal Penn.

[Ed Helms]

I'm Ed Helms.

[Kal Penn]

Ed and I are inviting you to join the best sounding book club you've ever heard with our new podcast, Earsay, the Audible and iHeart Audiobook Club.

[Ed Helms]

Each week we sit down with your favorite iHeart podcast hosts and some very special guests to discuss the latest and greatest audiobooks from audible.

[Kal Penn]

Listen to Earsay on America's number one podcast network, iHeart. Follow Earsay and start listening on the free iHeartradio app today.

[Lowe's Advertiser]

Free Stay cozy, stay home and save big online during Lowe's December Deal Drops because honestly, why go anywhere when the deals come to you? Check this out. Lowe's is going to give you two free select tools from dewalt Craftsman or Cobalt when you buy a select battery or combo kit. Yep, two tools free. It's basically a holiday miracle. Plus rewards members get free standard shipping all month long. Yet another reason not to leave your couch. Kick back, click around, let the savings roll in. Shop new December deal drops on Lowe's.com every week this month, fresh deals, cozy vibes, zero effort.

[TJ Maxx Advertiser]

Making the holidays magical for everyone on your list. It's no small feat, but with TJ Maxx, your magic multiplies with quality finds arriving daily through Christmas Eve. You'll save on luxe cashmere, the latest tech toys and more. So you can check off every name on your list and treat yourself to a holiday look that'll turn heads. Now you know where to go to make all that holiday magic. It's TJ Maxx. Of course, it's shaping up to be a very magical holiday.

[Ulta Beauty Advertiser]

Ulta Beauty's Big Holiday Beauty Sale is back with up to 50% off. Must have gifts shop irresistible deals like the Shark Beauty Flex Style and Benefit Cosmetics, Travel size mascaras with new offers weekly same day pickup or delivery and our trusted associates, we make holiday shopping effortless. Head into Ulta Beauty today. Ulta Beauty Gifting happens here.

[Famous Footwear Advertiser]

Hey, I'm Steffi. I go big for the holidays, so I'm going to Famous footwear. With over 800 stores, you're never far from the perfect gift. So make your list and make it famous. Buy one pair, get one half off at famous footwear or famous.com some some exclusions apply.

[Dr. Nicole Saffire]

Welcome to Wellness Unmass. I'm Dr. Nicole Saffire and this is your weekly rundown. Now, I was waiting until the very last minute to put this out because I wanted to see if the CDC's ACIP was going to hold a vote on whether or not to be giving universal hepatitis B vaccines to newborns. And to be honest, they're just talking, talking, talking. A lot of the members of this community love to hear themselves talk. So I got to get this out to you. I will update you on social media and next week what they end up voting on. But here's what's happening this week. Yesterday and today, a sip, the advisory committee on immunization practices through the CDC have been meeting to reconsider the longstanding recommendation that all newborns receive a birth dose of the hepatitis B vaccine. And I'll be honest, the meeting has been messy. Lots of tension coming down to one question. Do we need to universally vaccinate at birth, especially in mothers who are testing negative? That's a really good question. So mind you, this proposal is not about infants born to mothers who are positive for hepatitis B or who are unknown. Those infants would still absolutely receive the birth dose. They should. Now, the vote under consideration is really just for babies whose mothers have a confirmed negative hepatitis B test. For those infants, ACIP is weighing whether to eliminate the universal birth dose and instead allowed the first shot to be given at 2 months of age because they're not worried about the mother passing hepatitis B to the infant during birth. Now, this dose at two months is just to protect them for the future because you can still get hepatitis B. So here's the debate. The pro vaccine position saying, essentially there's decades of data of clear benefit. If you look at hepatitis B infections in the United States, they have gone down over the decades since we've been doing the universal newborn vaccine dose. Now those critics are pushing back, saying, yes, maybe the vaccine had some effect, but it's dishonest to say that it is wholly responsible for the decline in hepatitis B cases. And you know what? They're right. Because what else happened during this time? We have gotten much better at screening blood when it comes to hepatitis B cases that were happening because of blood transfusions, organ transplants, dialysis. And also when it comes to those who are getting hepatitis B from intravenous drug use. There's also now this clean needle spaces all throughout the country. So there are many variables that have contributed to the decline in hepatitis B cases. Even you can't just say it is 100% from the newborn vaccine dose. That isn't being entirely honest. Now the pro vaccine people are saying there's decades of data showing that this vaccine and the newborn is safe. Well, those criticizing it, they're not necessarily coming up with data showing it's not safe. But they are coming up with hypotheses saying it may be unsafe. And some of the hypotheses are. One of the well documented risk factors for vaccines is that people, babies specifically get fevers after vaccines. Well, if a newborn baby gets a fever, it's a whole process. It is admission to the hospital, spinal tap, blood cultures, it's a whole thing. Because fevers in a newborn is really a medical emergency. So should we be giving newborn babies a vaccine that has the potential to give them a fever and result in this downstream effect? And especially if we know that that mother was negative. And my personal opinion, no, probably not. I don't necessarily believe newborn babies. If the mother is documented negative hepatitis B and they are not living a high risk lifestyle for hepatitis B infection, I don't think that the newborn baby needs to get that shot before they leave the hospital. Now, should they be getting it at two months? Well, I'd love to see the data to support that at two months. It's beneficial. But the people who are saying let's go from newborn to two months, they're not presenting any data showing benefits or risk of doing it from newborn to two months. Is it gonna cause the same problems in a two month old? Maybe, maybe not. We don't necessarily worry the same amount about fevers in a two month old as we do in the newborn. But still, why two months? Why not six months? Why not six years? Especially with waning immunity over time. And we're more worried about kids getting hepatitis B the older they get and the more lifestyle decisions they make that could expose them to it, like unsafe sex practices, IV drug use, working in healthcare where they could get pimpricks, whatever it is. If we're talking about wanting to protect them from hepatitis B as they get older, why would we do it at two months? So I didn't really like that recommendation because there was no data on it. And I would like to open the conversation of even giving it later in life. Just like when you talk about giving the HPV vaccine, we give that to teens, teenagers, because you get human papilloma virus from sexual encounters. So why not consider the hepatitis B vaccine around the same time? So it is really risk based. That's my own personal opinion there. So it's not really, it's. It's really talking about timing here. Changing a long standing newborn recommendation without presenting new evidence. It's not science, it's policymaking without data. And that's what has so many clinicians raising an eyebrow and getting worked up right now people are saying if you change the universal newborn vaccine dose recommendation, babies aren't going to have access to this vaccine. And the reality is I don't really think that's true. What is the mantra of this current administration? This current CDC and ACIP is putting the autonomy back with the patients, back with the clinicians. So my guess what's going to come out of these two days worth of meetings is they are going to say if the mother is documented hepatitis B negative, not living a high risk lifestyle, IV drug user and so forth, then they're gonna say hold off on that newborn vaccine dose, but if you want it, you can still have it. After a conversation with the doctor, you're always gonna give that little caveat there because they don't wanna take things away, but they also don't wanna mandate it. So it's going to say, have a conversation with the doctor. They're still gonna recommend that newborn dose in hepatitis B positive moms or moms who we don't have a known hepatitis B status. But that raises another question. Why don't we know their status? We need to make sure that all pregnant women are getting the screening that they need, not just for hepatitis B, but for HIV and other communicable diseases because we have to protect these babies. So I implore OBGYNs and mothers out there make sure you're getting tested when you are pregnant. This protects your baby because if you have an infection, we want to know ahead of time so we can do everything we can to protect the baby. So we'll see what comes out. I will fill you in next week. What they end up voting. The hepatitis B birth dose remains one of the most effective and well studied tools in modern pediatrics. We know that it does reduce the risk of infection. It absolutely does. Who needs it when they should take it? That's what's up for discussion here and I am happy to see this discussion happening. If we want families to trust vaccine recommendations, then every change must be backed by transparent, compelling evidence. The current ACIP meeting is a lot of conjecture, a lot of people just wanting to hear themselves speak, not really presenting any new science. And that's what makes me a little bit uncomfortable. But I am still very glad to see the conversation being had. And that's it. I'm Dr. Nicole Safire, this is Wellness Unmask and your weekly rundown. Listen to Wellness Unmass on iheartradio wherever you get your podcasts and we will see you next time.

[Lowe's Advertiser]

Stay cozy, stay home and save big online during Lowe's December deal drops because honestly, why go anywhere when the deals come to you? Check this out. Lowe's is Gonna give you two free select tools from DeWalt, Craftsman or Cobalt when you buy a select battery or combo kit. Yep, two tools free. It's basically a holiday miracle. Plus rewards members get free standard shipping all month long. Yet another reason not to leave your couch. Kick back, click around, let the savings roll in. Shop New December deal drops on Lowes.com every week this month. Fresh deals, cozy vibes, zero effort.

[Kal Penn]

Hey audiobook lovers, I'm Cal Penn.

[Ed Helms]

I'm Ed Helms.

[Kal Penn]

Ed and I are inviting you to join the best sounding book club you've ever heard with our new podcast, Irsay The Audible and iHeart audiobook.

[Ed Helms]

Each week we sit down with your favorite iHeart podcast hosts and some very special guests to discuss the latest and greatest audiobooks from audible.

[Kal Penn]

Listen to Earsay on America's number one podcast network, iHeart. Follow Earsay and start listening on the free iHeartradio app today.

[Ulta Beauty Advertiser]

Ulta Beauty's big holiday beauty sale is back with up to 50% off. Must have gifts Shop irresistible deals like the Shark Beauty Flex Style and Benefit Cosmetics Travel size mascaras with new offers weekly same day pickup or delivery and our trusted associates. We make holiday shopping effortless. Head into Ulta Beauty today. Ulta Beauty Gifting happens here.

[Kawi Power Advertiser]

New school year, new routines and somehow your calendar is already full. When life gets hectic, Kawi Power's got your back. We make the food you crave made better for you like thin and crispy cauliflower crust pizzas, all natural chicken tenders and nostalgic pizza snacks. Ready in minutes and something the whole family can agree on. Caulifowwer is available in freezer aisles nationwide. Visit eatcolipower.com to find a store near you.

[Everytown for Gun Safety Representative]

Mothers, fathers, children, friends Gun violence doesn't discriminate Every day in America, 125 people are shot and killed at Everytown for Gun Safety Action Fund. We believe in a future where we can enjoy the movies or a concert without looking for the nearest exit. We've helped pass life saving laws in states across the country. When you give online this giving Tuesday through December 5th, your gift to the Everytown Action Fund will be matched for double the impact on our work to end gun violence. Go to everytown.org to make your matched donation today.